TheProfitWatch

SRZN - Surrozen, Inc. Common

Day 1m 10m 60m PreMarket Market AfterHours Gap
13.64 0.11 (0.83%) --- --- --- --- 0.11 (0.83%) --- ---

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
2.55
Diluted EPS:
2.55
Basic P/E:
5.3922
Diluted P/E:
5.3922
RSI(14) 1m:
43.59
VWAP:
13.75
RVol:
0.1068

Events

Period Kind Movement Occurred At

Related News